Cancer Immunotherapy by Delivering Class II MHC Antigens Using A VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-US-07
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
US20160312242A1
Application Number
15/104,785
IC
NCI
Date Filed
Date Issued
Patent PDF